🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

FDA approves subcutaneous form of atezolizumab for use where IV already approved (including NSCLC and SCLC). Based on IMscin001 showing OS, RR, PROs, safety were similar with far shorter administration time. targetedonc.com/view/fda-appro…

BREAKING: U.S. FDA Approves Pembrolizumab Plus Chemo for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma #lcsm #oncology onclive.com/view/fda-appro…

New data: Most doctors take less than 3 weeks of vacation a year, and 70% work while on vacation. Both factors were associated with higher rates of burnout. We have to stop the vacation shaming and find realistic strategies for coverage without burdening our colleagues.

#Osimertinib, FDA-approved for stage-III EGFR-mNSCLC after chemoXRT, #LAURA Ph-III trial. Remarkable PFS of 39.1 months compared to 5.6 months with a HR of 0.16. The 2-year PFS; 65% vs 13%, along with enhanced CNS PFS. Grade ≥3 AE 35% vs 12%. #LungCancer #CancerResearch

From fee-for-service to value-based care—in the final hr of #ASCOQLTY24, we discussed how the future of care delivery hinges on aligning reimbursement with patient needs/outcomes. This can be driven by strategic policy & legislative efforts, possible even in a gridlocked Congress

Exciting times in #NSCLC with multiple immunotherapy approvals! 🎉 But navigating these options can be complex. Glad to partner with Oncology Learning Network to create patient case-based education, bridging the gap between advancements and real-world application. Let’s ensure these

If you’re available at 11 am ET tomorrow, we’d love to have you join the discussion: provaeducation.gathered.com/invitation?ref… #lcam #lcsm #cme #ce

International Faculty: Upal Basu Roy from LUNGevity Foundation, Suresh S. Ramalingam, MD, FASCO from Winship Cancer Institute of Emory University and Geetika Srivastava MD MSPH from the U.S. FDA

FDA approves #Durvalumab for limited-stage #SCLC after the ADRIATIC trial shows a game-changing median OS of 55.9 months vs 33.4 months! A new standard of care. #LungCancer #Oncology #lcsm fda.gov/drugs/resource…

Jumpstart your job search with our ASCO Connection article! Uncover secrets for navigating your career post-fellowship. We discuss the pros/cons of community, academic, and hybrid practices to help you find your ideal path. Arya Roy Matthew Kurian, MD tinyurl.com/yeyu6wp5

Planning your career after fellowship? Our article on ASCO connection explores the pros & cons of academia, community & hybrid practices! A practical guide to help fellows make informed decisions! Matthew Kurian, MD Rajat Thawani ASCO TECAG Ohio State Medical Oncology Hem-Onc Fellows Network

“Officially board-certified in Hematology and Oncology! Grateful for the journey, the support, and the opportunity to make a difference in the lives of patients. Excited for what’s ahead! #BoardCertified #Oncology” ASCO TECAG ASCO ASH #HEMEONC

Up to 40% of cancers are preventable with lifestyle changes: avoid tobacco, eat healthy, stay active, and regular cancer screenings. Take control of your health today. #CancerAwareness #CancerPrevention #HealthTips #EarlyDetection #Wellness pubmed.ncbi.nlm.nih.gov/38990124/

🚨 Don’t miss out on the ASCO Editorial Fellowship! 🌟 As a proud alumnus, I strongly recommend it. Journal of Clinical Oncology ASCO ASCO TECAG 📚 Learn from the experts ✍️ Valuable insights the editorial process 🌍 Expand your professional network 🔗 ascopubs.org/fellowship

Navigating the J1visa waiver while building a career in HemeOnc? We wrote about the challenges, strategies, and tips for finding a heme/onc job in the U.S. on a J-1 visa — while staying true to your long-term goals. Ivy Riano, M.D. ASCO University of Vermont #MedTwitter #Oncology #IMG

If you're a trainee or early career attending #ASCO25, stop by the Trainee and Early Career Lounge for Panel Talks, Roundtable Sessions, and Networking Events (+ mentoring and refreshments!) @asco asco.org/annual-meeting…

🚨Mark your calendars for the ASCO TECAG town hall on ways to navigate #ASCO25! From logistics, to intentional planning and to enjoyment! 💫"So You’re Going to the ASCO Annual Meeting… What to Do to Make the Most of It" 📅 Thu 5/22 3-4 pm ET 👉Register tinyurl.com/33bbtkzj

Will you be at #ASCO25? Don’t miss the Trainee & Early Career Lounge (TEC) — the ultimate space to recharge 🛋️, sip on ☕, and connect with fellow students, residents, fellows, and junior faculty! 🌟 Highlights: 📋 Protocol to Publication Roundtable 📱 Leveraging Social Media

📚 Join us at #ASCO25 for Publication 101: Peer Review & Becoming a Successful Author 🗓️ June 2 | ⏰ 10:15–11:15 AM 📍Trainee & Early Career Lounge Get practical tips to boost your academic writing, peer-review & publishing success! #OncTwitter #ASCO #ASCOTECAG #UVM

Our #ASCO25 JCO Central lounge in Room S403b is open to all today from noon to 5 pm. Info & programming: brnw.ch/21wT2Z1 Today @ 11:45am #JCO EIC Jonathan Friedberg & Dr. Kathy Miller will host a grant writing & publishing workshop in the Trainee & Early Career Lounge.